Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy
Authors:
- Donald D. PriceDPDonald D. Price
- Ronald L. HayesRHRonald L. Hayes
- Juan LuJLJuan Lu
- David J. MayerDMDavid J. Mayer
- Hanan FrenkHFHanan Frenk
- 1 March 1993
- journal article
- Published by Elsevier in Brain Research
- Vol. 605 (1) , 164-168
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Spatial patterns of spinal cord [14C]-2-deoxyglucose metabolic activity in a rat model of painful peripheral mononeuropathyPain, 1992
- Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonistsPain, 1992
- Pretreatment with gangliosides reduces abnormal nociceptive responses associated with a rodent peripheral mononeuropathyPain, 1992
- NMDA Antagonist Neurotoxicity: Mechanism and PreventionScience, 1991
- Effects of NMDA receptor antagonists following spinal ischemia in the rabbitExperimental Neurology, 1990
- Further evidence for ‘pain-related’ behaviours in a model of unilateral peripheral mononeuropathyPain, 1990
- Selective depression of N-methyl-d-aspartate-mediated responses by dextrorphan in the hippocampal slice in ratNeuropharmacology, 1989
- Delayed treatment with dextromethorphan and dextrorphan reduces cerebral damage after transient focal ischemiaNeuroscience Letters, 1988
- A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in manPain, 1988
- Anticonvulsant effects of dextrorphan in rats: Possible involvement in dextromethorphan-induced seizure protectionLife Sciences, 1988